Mercy Medical Center Names Lisa Casasanta VP of Population Health
SPRINGFIELD — Lisa Casasanta has been named vice president of Population Health for Mercy Medical Center and the Sisters of Providence Health System (SPHS). In this role, she is responsible for overseeing and aligning population-health strategies and the associated performance metrics.
Additionally, she develops business plans that support affiliation with community partners; serves as a key partner with affiliated accountable-care organizations and regional leadership in the development of market growth plans; and provides direction, leadership, and management of all population-health strategies, including transition of care, chronic-disease management, and Bundled Payments for Care Improvement (BPCI) programs.
Most recently, Casasanta served as director of Population Health Marketing and Managed Markets Marketing for Boehringer-Ingelheim Pharmaceuticals in Ridgefield, Conn. She has also served as director of the Customer Marketing Group at Pfizer in New York, and as director of Strategic Initiatives at Pfizer Health Solutions in Santa Monica, Calif. and New York.
Casasanta received her bachelor’s degree in medical technology from the University of Connecticut and her master of public health degree from the UConn School of Medicine. She holds a First Line Management certification and a Franklin Covey Microsoft Project certification.
“A proven leader, Lisa understands the importance of high-quality care delivery and appropriate care management for patients across our continuum,” said Dr. Scott Wolf, president of Mercy Medical Center and SPHS. “This ability, coupled with her broad base of experience and knowledge of disease management, make Lisa a great asset to our team at Mercy Medical Center and the entire health system.”